Innate Pharma (IPHA) Total Liabilities (2017 - 2026)
Innate Pharma's Total Liabilities was $87.45 million in the quarter ended Jun 30, 2026, down 12.0% from $99.38 million a year earlier.
Powered by 
Analysis
Innate Pharma (IPHA) Total Liabilities (2017 - 2026) Analysis & Trends
As of Dec 31, 2025, Total Liabilities at Innate Pharma came in at $95.38 million, down 13.8% from the prior year.
- Total Liabilities has now declined for four consecutive years, with a five-year compound annual growth rate of -11.2% (years ended Dec 2020 to Dec 2025).
- In earlier years, Total Liabilities was $110.64 million in the year ended Dec 31, 2024 (-22.7%), $143.1 million in the year ended Dec 31, 2023 (-11.7%), $162.01 million in the year ended Dec 31, 2022 (-11.5%) and $183.1 million in the year ended Dec 31, 2021 (+5.9%).
- The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly Total Liabilities in data going back to the quarter ended Dec 31, 2017.
- The best year-over-year quarter for Total Liabilities over five years was the quarter ended Jun 30, 2023 (growth of 39.4%); the worst was the quarter ended Jun 30, 2022 (a decline of 31.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,140.41 Bn | 1,108.99 Bn | 19.71 Bn | 108.40 Bn |
| 2 | Johnson & Johnson | 618.57 Bn | 537.10 Bn | 17.26 Bn | 116.09 Bn |
| 3 | AbbVie | 509.95 Bn | 483.06 Bn | 12.70 Bn | 141.05 Bn |
| 4 | Merck | 366.63 Bn | 321.01 Bn | 12.21 Bn | 87.82 Bn |
| 5 | Novartis Ag | 298.47 Bn | 262.46 Bn | 11.24 Bn | 80.09 Bn |
| 6 | Astrazeneca | 263.21 Bn | 236.89 Bn | 12.86 Bn | 65.46 Bn |
| 7 | Amgen | 236.71 Bn | 192.11 Bn | 7.24 Bn | 83.95 Bn |
| 8 | Gilead Sciences | 193.05 Bn | 167.25 Bn | 6.22 Bn | 37.53 Bn |
| 9 | Pfizer | 171.45 Bn | 118.10 Bn | 10.94 Bn | 115.64 Bn |
| 10 | Innate Pharma | 140.66 Mn | -66.54 Mn | - | 85.93 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 85.93 Mn |
| Dec 31, 2025 | 99.17 Mn |
| Jun 30, 2025 | 102.96 Mn |
| Dec 31, 2024 | 106.38 Mn |
| Jun 30, 2024 | 131.39 Mn |
| Dec 31, 2023 | 136.46 Mn |
| Jun 30, 2023 | 153.44 Mn |
| Dec 31, 2022 | 154.73 Mn |
| Jun 30, 2022 | 171.43 Mn |
| Dec 31, 2021 | 181.26 Mn |
| Jun 30, 2021 | 157.89 Mn |
| Dec 31, 2020 | 186.28 Mn |
| Jun 30, 2020 | 140.93 Mn |
| Dec 31, 2019 | 206.06 Mn |
| Dec 31, 2018 | 324.87 Mn |
| Dec 31, 2017 | 201.90 Mn |
API Access
Innate Pharma Total Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-liabilities&ticker=IPHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-liabilities", "ticker": "IPHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-liabilities&ticker=IPHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();